Initiation of the Epstein-Barr virus (EBV) lytic cycle is dependent on expression of the viral transactivator Zta, which is encoded by the BZLF1 gene. Described here is an initial mapping of the regions of Zta involved in activating transcription. The data indicate that the amino-terminal 153 amino acids of Zta are important for activity, and in particular the region from residues 28 to 78 appears to be critical for Zta function. However, other features of Zta may be important for activity since a Gal4-Zta chimeric protein, generated by fusing the amino-terminal 167 residues of Zta to the DNA binding domain of the yeast transactivator Gal4, transactivated a minimal promoter containing one upstream Gal4 binding site but was unable to exhibit synergistic transactivation when assayed with a reporter containing five upstream Gal4 binding sites.
Epstein-Barr virus (EBV) is a human lymphotrophic herpesvirus that predominantly establishes a latent infection in B lymphocytes. The EBV lytic cycle can be induced by a variety of reagents, including phorbol esters, butyrate, ionophore, and anti-immunoglobulin (1, 22, 28, 37, 40) . One of the earliest events following stimulation of the lytic cycle is expression of the viral BZLF1 gene (34) . The BZLF1 gene encodes a viral transactivator, Zta (also referred to as ZEBRA and EB1), which plays a pivotal role in the initiation of the lytic cascade (5, 6, 31) .
Zta contains a basic region with homology to the AP-1 family of transcription factors and has been shown to bind with high affinity to a consensus AP-1 site (10) . The recognition target of Zta is, however, somewhat degenerate (10, 12, 13, 25, 26) , and we have identified a divergent Zta binding site (ZIIIB [12] ) within the BZLF1 promoter that is involved in autoregulation (12, 38) . The carboxy-terminal domain of Zta (amino acids 194 to 245; see Fig. 5 ) mediates homodimerization (3, 14, 23, 25) through a coiled-coil interaction (14, 23) . Here, we report a functional analysis of the aminoterminal portion of Zta and map a region which appears to be critical for mediating transcriptional activation.
MATERIALS AND METHODS
Cell culture, transfections, and chloramphenicol acetyltransferase (CAT) assays. The EBV-negative Burkitt's lymphoma cell line DG75 was grown at 37°C in RPMI 1640 medium (GIBCO Laboratories) containing 10% newborn calf serum. DG75 cells were transfected by using DEAE-dextran as previously described (11) , with the following modifications. Cells (107 per transfection) were spun down at 1,000 x g, washed once with RPMI 1640 without serum, and resuspended at a concentration of 2 x 107 cells per ml in RPMI 1640 containing 1 mg of DEAE-dextran per ml. Cells (107; 0.5 ml) were added to sterile tubes containing 2 ,ug of each relevant plasmid in 0.5 ml of RPMI 1640 without serum, incubated at 37°C for 30 min, and subjected to dimethyl sulfoxide shock (final concentration of 7%) for 2 min. Ten milliliters of RPMI 1640 with 10% serum was added to the transfection mixture, and the cells were recovered by centrifugation at 1,000 x g for 5 min, resuspended in 10 ml of * Corresponding author.
RPMI 1640 containing 10% serum, and cultured at 37°C in a 5% CO2 incubator.
DG75 cells were harvested 48 h posttransfection by centrifugation at 1,000 x g, washed once with phosphatebuffered saline, and suspended in 0.1 ml of 0.25 M Tris chloride, pH 7.5. The cell suspension was lysed by three rounds of freeze-thawing, and the cellular debris was removed by centrifugation in a microcentrifuge. CAT activity of the extract was determined as previously described (18) , and the extent of acetylation was determined by counting the acetylated species of chloramphenicol, using a Betascope (Betagen).
Construction of Zta mutants and expression vectors. The
Zta in vitro expression vectors were constructed by a two-step cloning procedure starting with a full-length Zta cDNA cloned in the Bluescript plasmid (Stratagene). First, a Scal restriction site (AGT ACT) was introduced at various positions in the Zta coding sequence by site-directed mutagenesis (15) . Introduction of the ScaI sites resulted in the mutation of two adjacent residues to serine (AGT) and threonine (ACT). The internal Zta deletion mutants were generated by mixing and matching amino-terminal regions from various mutants with carboxy-terminal regions from other mutants through their respective Scal sites. The set of amino-terminal nested deletions was generated by linking the 5' end of each mutant to an adaptor containing two in-frame methionine translation initiation codons. In vivo mutant Zta expression vectors were generated by using the strategy described above. The starting plasmid for mutagenesis was the genomic BZLF1 gene cloned downstream of the simian virus 40 (SV40) early promoter and enhancer in the Bluescript plasmid (Stratagene). Prior to generation of Zta deletion mutants, the 3' end of the BZLF1 gene was mutagenized to introduce the SV40 large T-antigen nuclear localization signal (PKKKRKV) (21) .
Gal4-Zta was generated by cloning a polymerase chain reaction product containing sequences encoding amino acids 1 to 167 of Zta in frame with the Gal4 DNA binding domain (27) . This construct was generated twice, employing two independent polymerase chain reactions to ensure that the observed activity was not due to possible Taq polymerase errors.
To generate 3 x (ZIIIB)pG4, a double-stranded oligonucleotide with three copies of the ZIIIB ZEBRA recognition 922 Burkitt's lymphoma cell line DG75 with either a control expression vector or the same vector with the BZLF1 gene cloned downstream of the SV40 early promoter and enhancer (SVZwt). (B) Activities of Gal4 chimeric proteins. The Gal4-Zta chimera was generated by cloning the region of the BZLF1 gene encoding the amino-terminal 167 residues of Zta downstream and in frame with a truncated Gal4 gene encoding the amino-terminal 147 residues of Gal4. The Gal4-VP16 chimera has been previously described (33) .
sequence was introduced into the BamHI and XbaI sites of pG4 (19) . The following oligonucleotides were annealed: 5'-CTAGCAGGCATTGCTAATGTACCCAGGCATTGCTA ATGTACCCAGGCATTGCTAATGTACC-3' and 5'-GATCG GTACATTAGCAATGCCTGGGTACATTAGCAATGCC TGG GT AC AT TA GC AA TG CC TG-3'. 3 x (ZIIIB)pG4CAT was generated from 3 x(ZIIIB)pG4 by replacing globin sequences with the bacterial CAT gene. Specifically, a blunted HindII-BamHI fragment from pSV2CAT (18) containing the CAT gene was cloned downstream of the ,-globin TATA box into the PvuII-BglIH sites of 3 x (ZIIIB)pG4.
Electrophoretic mobility shift assays. Zta in vitro expression plasmids were prepared and linearized by standard procedures (29) . In vitro transcripts were generated by using T3 RNA polymerase (Stratagene), followed by in vitro translation of a fraction of the transcription reaction employing wheat germ extract (Promega) with [35S] (29) , and the upper buffer was prewarmed to 28°C.
In vitro transcription assay and Si nuclease protection. Whole cell extracts were prepared from the EBV-negative cell line DG75 as described previously (11) . Transcription reactions (9) were performed in a 50-pA reaction volume with the following final concentrations: 10 mM HEPES (7.9), 10% glycerol, 60 mM KCl, 8 mM MgCl2, 0.1 mM EDTA, 0.25 mM dithiothreitol, 0.6 mM ATP, 0.6 mM GTP, 0.6 mM CTP, and 0.6 mM UTP. In addition, 200 ng of reporter plasmid, 1 ,ug of nonspecific supercoiled plasmid DNA, 300 ,ug of DG75 whole cell extract, 2 ,u of RNasin (Promega), and the indicated amounts of in vitro translation reaction mixture were added to each reaction mixture. Reactions were allowed to proceed for 1 h at 28°C. Samples were then subjected to phenol and phenol-chloroform extractions and precipitation with ethanol. The samples were analyzed by S1 analysis as previously described (39) . Samples were resuspended in formamide loading buffer and separated on a 10% acrylamide sequencing gel.
Immunofluorescence. HeLa cells were transiently transfected with 2 p.g of SVZwt, SVZd27/53(nls), or SVZd52/78 in 2 ml of Opti-mem (GIBCO) with 10 RI1 of lipofectin (Bethesda Research Laboratories) per transfection for 16 h. The medium was replaced with RPMI containing 10% fetal bovine serum, incubated for 24 h at 37°C, and passed to four-well glass chamber slides (Lab-Tek). The cells were grown for another 48 h, fixed with 0.5% paraformaldehyde, and treated with 1 ,ug of 4,6-diamino-2-phenylindole (Sigma) per ml in addition to rabbit anti-Zta polyclonal antibody and fluorescein isothiocyanate-conjugated goat anti-rabbit antibody. The nuclei and ZEBRA protein were then visualized by fluorescence microscopy.
RESULTS
The amino-terminal region of Zta is involved in transcriptional activation. Zta transactivation of target promoters has previously been shown to be dependent on the presence of a specific Zta recognition sequence(s). Similar to many transcription factors, Zta exhibits homosynergistic transactivation (Fig. 1A) . We have previously shown that binding of Zta to adjacent sites is not cooperative (12) . Comparison of the level of transactivation by Zta of a reporter construct containing a single copy of the Zta ZIIIB binding site (ca. 8-fold) with that of the same parent construct containing three copies of the ZIIIB binding site (ca. 200-fold) revealed a much greater than 3-fold increase in transactivation when three copies of the ZIIIB site were present (Fig. 1A) .
To determine whether the amino-terminal region of Zta mediates transactivation, a Gal4-Zta chimeric protein was generated that contained the amino-terminal 147 residues of Gal4 to which the amino-terminal 167 residues of Zta were fused. As a control, we used a previously described Gal4-VP16 chimeric protein (33) (Fig. 1B) (20, 24) .
Cell extracts competent for activated transcription were generated from the EBV-negative Burkitt's lymphoma cell line DG75. The reporter construct used for these studies was derived from plasmid pG4 (19) , which contains a minimal P-globin promoter. Three copies of a Zta binding site, ZIIIB, were cloned upstream of the ,-globin TATA box to generate 3 x (ZIIIB)pG4. Addition of in vitro-generated Zta to the transcription reaction mixture containing the parent pG4 reporter plasmid (no ZIIIB sites) had little affect on transcription (Fig. 2) . However, addition of increasing amounts of in vitro-translated Zta to the transcription reaction mixture containing the 3 x (ZIIIB)pG4 plasmid resulted in a large stimulation of transcription initiating from the P-globin promoter (Fig. 2) . Addition of equivalent amounts of control wheat germ translation extract had little effect on transcription from 3 x (ZIIIB)pG4. The ZIIIB site, which is a Zta binding site found within the BZLF1 promoter (12), differs from the consensus AP-1 sequence at three positions and does not bind a heterodimer of Jun and Fos but still binds Zta with relatively high affinity (35) . Thus, it was chosen for this study in an effort to avoid complicating effects due to binding of AP-1 factors. It is noteworthy that in the absence of added Zta, the presence of the ZIIIB binding sites did not signifi- 2 . Specific activation of transcription by Zta in an in vitro transcription system. Whole cell extracts were generated from the EBV-negative cell line DG75, and Zta protein was generated by translating RNA in a wheat germ in vitro translation system. Control extract was generated in an identical manner except that no RNA was added to the translation reaction mixture. Transcription products were analyzed by S1 nuclease protection, using a 32P-labeled antisense oligonucleotide probe spanning the transcription start site. Protected fragments were resolved on a denaturing 10% acrylamide gel. N.E., no added wheat germ translation extract.
cantly increase transcription from the ,3-globin promoter [compare no-extract lanes for pG4 versus 3 x (ZIIIB)pG4], indicating the general absence of endogenous activator activity in the DG75 extract which can function via the ZIIIB domains.
Zta mutants containing deletions in the amino-terminal region of the protein retain DNA binding activity. To map the region(s) of Zta involved in activating transcription in the in vitro transcription system, an extensive series of Zta deletion mutants was generated (Fig. 3) . This series includes a set of 27-amino-acid internal deletion mutants in addition to a set of nested amino-terminal deletions and two sets of nested deletions extending amino terminal from residue 128 and residue 153.
Previous reports have demonstrated that deletion of sequences amino terminal to the basic region of Zta affect DNA binding affinity (32, 35) . To establish the ability of Zta deletion mutants to specifically bind DNA, an electrophoretic mobility shift analysis (EMSA) (16) was performed under conditions approximating those used in the in vitro transcription assay (Fig. 4) . Amino-terminal deletion of sequences up to residue 153 appeared to have little effect on the affinity of Zta for an oligonucleotide containing the ZIIIB Zta binding site. However, deletion of sequences to residue 167 abrogated binding activity (data not shown), and therefore mutants containing deletions beyond residue 153 were not used in the transcription assays. Before in vitro-translated Zta mutants were assayed for transcriptional activity, EMSA was routinely performed and the amounts of the translation products were standardized with respect to binding.
Two regions of Zta appear to be important for activation of transcription in vitro. A typical in vitro transcription assay with Zta deletion mutants is shown in Fig. 5 , and the data from several independent experiments are summarized in Fig. 3 . Deletion of the amino-terminal 28 residues of Zta modestly reduced Zta activity, but deletion to residue 53 significantly diminished transactivation to 16% of that ob- Fig. 3) .
Notably, the activities exhibited by the various Zta dele- To control for the amount of wheat germ extract added to each reaction, control extract (Cntl. Ext.) was added to each reaction mixture to compensate for differences in the amount of specific translation product added (10 ,ul total In vivo analysis of Zta deletion mutants. The results obtained with the Zta deletion mutants in the in vitro transcription system differ somewhat from those obtained by Giot et al. (17) . These investigators used a similar series of Zta deletion mutants to characterize Zta transactivation in vivo. They found that a series of deletions in the region from residues 25 to 93 dramatically reduced Zta-mediated transactivation. While the in vitro transcription results presented here indicate that the region from residues 27 to 78 is important for transactivation, the deletions in this region appeared to have a more moderate effect on activity.
To assess the influence of deletions in the activation domain of Zta on transactivation monitored in vivo, expression vectors were generated that produce mutant Zta proteins in vivo bearing ca. 27-amino-acid deletions (Fig. 6A) . Since the nuclear localization signal(s) for Zta has not yet been critically assessed (17), we attempted to ensure that the mutants localized to the nucleus by engineering the expression plasmids to express proteins containing the SV40 nuclear localization signal (PKKKRKV) (21) at their carboxy termini. The addition of these amino acids to Zta did not affect activity (data not shown).
Mutant Zta expression plasmids were cotransfected into the EBV-negative Burkitt's lymphoma cell line DG75 with a reporter plasmid containing three copies of the ZIIIB domain cloned upstream of the minimal 3-globin promoter, 3 x (ZIIIB)pG4CAT, which was derived from the reporter plasmid used in the in vitro transcription system (Fig. 6B) .
The results of cotranfecting the 3 x (ZIIIB)pG4CAT construct with wild-type Zta and the Zta deletion mutants are shown in Fig. 6B . It is worth noting that the 3 x(ZIIIB) pG4CAT vector exhibited very low background activity in the absence of Zta and therefore provides an ideal vector for characterizing Zta transactivation. Deletion of residues 27 to 53 had the greatest impact on Zta transactivation, diminishing Zta activity to approximately 3% of the wild-type protein level, which is more in line with the magnitude of effect observed by Giot et al. (17) employing similar deletions in this region of Zta. These results indicate that deletions in this region of Zta have a greater impact on transactivation in vivo than in an in vitro transcription system. It should be emphasized, however, that Zd27/53 does retain the ability to transactivate the 3 x (ZIIIB)pG4CAT reporter construct. When 40 ,ul of cell extract was assayed for CAT activity, Zd27/53 activated transcription 80-fold (Fig. 6B) .
The relative activities of the other 27-amino-acid deletion mutants are in reasonably good agreement with the results obtained in vitro. Deletion of residues 53 to 78 had a significant impact on transactivation, exhibiting transactivation that was only about 17% of wild-type Zta transactivation. This is slightly lower than the observed relative activity of this mutant in the in vitro transcription system. Deletion of residues 103 to 128 and residues 128 to 153 had a smaller effect on Zta transactivation, reducing Zta activity to 46 to 47% of the wild-type Zta level, while deletion of residues 78 to 103 had no apparent effect on activity.
To ensure that these mutants were expressed correctly, a fraction of each transfection was harvested and assayed for mutant Zta expression by immunoblotting with a polyclonal anti-Zta antibody (Fig. 6C) . All of the mutants appeared to be present in approximately the same abundance. It is important to note that although slight differences in migration rates were observed among the Zta mutants, an analogous series of mutants generated by coupled in vitro transcription and translation exhibited the same migration J. VIROL. The inability of the Gal4-Zta chimera to exhibit synergistic transactivation raises the possibility that another region of Zta is required for synergy. With respect to this point, Giot et al. (17) have reported that synergy between Zta and the EBV BRLF1-encoded transactivator may involve the DNA binding domain of Zta. In a separate system, it has recently been reported that mutation of a glutamic acid residue to an alanine in one of the zinc fingers of the transcription factor ADR1 abolished transactivation but did not affect DNA binding (36) .
In this study, a deletional analysis of the amino terminus of Zta has been performed, and the results of in vivo and in vitro assays are presented. The in vivo data indicate that the region of Zta from residues 27 to 53 is critical for efficient transactivation. However, this deletion had a smaller impact on Zta transactivation in the in vitro transcription system. One clear difference between the in vivo and in vitro systems is that any posttranslational modifications involved in modulating Zta activity would most likely not take place in the in vitro transcription system. It is possible that such modifications have a differential effect on the Zd27/53 mutant.
With the exception of the Zd27/53 mutant, the activities exhibited by the Zta mutants in the in vivo and in vitro systems correlated well. It is clear from both the in vivo and in vitro results that the amino-terminal region of the activation domain from residues 27 to 78 is important for Zta activity. Although not as striking, it is also clear that deletion (1) . Proline residues are circled, glutamine residues are boxed, and acidic residues are in boldface.
of residues between 102 and 153 affects activity both in vivo and in vitro. It is possible that deletions in this region simply affect the conformation of upstream sequences and these sequences do not play a direct role in activation. However, we favor the idea that these sequences are directly involved in transcriptional activation, since Zd27/53 and Zd52/78 still retain low but significant activity. Moreover, Zd78, in which the first 78 amino acids are deleted, consistently demonstrates low-level activation, while Zd153 is consistently inactive (Fig. 3 and 5) .
A detailed mutational analysis of the herpes simplex virus VP16 acidic activation domain has indicated that activation is dependent on the concerted contribution of multiple acidic residues (8) . However, it was also shown that mutation of a specific hydrophobic residue in the VP16 activation domain abolished activation. The latter result suggests that either specific hydrophobic interactions with protein partners or intramolecular folding are important for activation. Other reports have suggested the importance of glutamine residues for transcriptional activation by Spl (7) and proline residues in the activation domain of CCAAT transcription factor (30) .
While Zta's activation domain is moderately rich in glutamine and proline residues, it also contains several acidic residues (Fig. 8) . In addition, the activation domain contains a number of hydrophobic residues. To further assess the contribution of specific residues in directing transcriptional activation, a detailed mutational analysis, particularly in the region from residue 27 to 78, will be required.
